Literature DB >> 19542031

AJPH endorsement of transparency, clarity, and rigor.

Roger Vaughan.   

Abstract

Mesh：

Year:  2009        PMID： 19542031      PMCID： PMC2707488          DOI： 10.2105/AJPH.2008.154609

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  14 in total

Review 1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D Altman
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

Review 2.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

3.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

Authors:  Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  N Engl J Med       Date:  2004-09-08       Impact factor: 91.245

4.  CONSORT statement: extension to cluster randomised trials.

Authors:  Marion K Campbell; Diana R Elbourne; Douglas G Altman
Journal:  BMJ       Date:  2004-03-20

5.  Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement.

Authors:  Don C Des Jarlais; Cynthia Lyles; Nicole Crepaz
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

6.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Douglas G Altman; Stuart J Pocock; Stephen J W Evans
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

7.  Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.

Authors:  Joel J Gagnier; Heather Boon; Paula Rochon; David Moher; Joanne Barnes; Claire Bombardier
Journal:  Ann Intern Med       Date:  2006-03-07       Impact factor: 25.391

8.  Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

Authors:  Isabelle Boutron; David Moher; Douglas G Altman; Kenneth F Schulz; Philippe Ravaud
Journal:  Ann Intern Med       Date:  2008-02-19       Impact factor: 25.391

9.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

10.  Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'.

Authors:  Sally Hopewell; Douglas G Altman; David Moher; Kenneth F Schulz
Journal:  Trials       Date:  2008-04-18       Impact factor: 2.279
View more
  2 in total

1.  Reporting guidelines and the American Journal of Public Health's adoption of Preferred Reporting Items for Systematic reviews and Meta-Analyses.

Authors:  Kenneth R McLeroy; Mary E Northridge; Hector Balcazar; Michael R Greenberg; Stewart J Landers
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

2.  Leading the way toward the next 100 years of publishing.

Authors:  Mary E Northridge; Hector Balcazar; Georges C Benjamin
Journal:  Am J Public Health       Date:  2010-09-23       Impact factor: 9.308
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.